An examination into the role of amygdala glutamatergic neurons in sevoflurane's impact on cognitive impairments was conducted by administering buthionine sulfoximine (BSO), a substance that hampers the activity of glutaminase—an enzyme essential for the production of glutamate in neurons. This evidence concerns the gene GLS and Cognitive impairment.